Ian Dixons new venture about to list soon,Thread opened under EX1. Exopharm. The "juice" from stem cells.https://exopharm.com/Raised max amount and was scaled back. No retail offer.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game